Target intelligence / Profile preview

SLIT-ROBO Rho GTPase-activating protein 3 (SRGAP3)

Target
SRGAP3
Molecular classification
Enzyme, Rho GTPase-activating protein
01

Overview

SLIT-ROBO Rho GTPase-activating protein 3 (SRGAP3) is a protein encoded by the SRGAP3 gene on chromosome 3, primarily expressed in the central nervous system, especially in regions critical for higher cognitive functions such as the hippocampus and cortex[1][4]. It acts as a GTPase-activating protein (GAP) for RAC1, and potentially CDC42, thereby negatively regulating specific Rho family small GTPases involved in actin cytoskeleton remodeling and neuronal plasticity[1][2][6]. SRGAP3 is an intracellular effector in the Slit-Robo signaling pathway that governs neuronal migration and axonal branching, and its disruption has been linked to intellectual disability and abnormal neuronal development[1][2][3]. SRGAP3 is also referred to by alternative names such as MEGAP (Mental disorder-associated GAP) and ARHGAP14, and shares structural and functional similarities with other RhoGAP family proteins[1]. The protein contains key functional domains: an SH3 domain, a FES/CIP4 (FCH) domain, and the RhoGAP domain[1]. Loss or mutation of SRGAP3 can cause severe neurodevelopmental phenotypes due to impaired neuronal migration and synaptic assembly[1][2][5].

Other names
MEGAPARHGAP14KIAA0411KIAA1156WRPMental disorder-associated GAPRho GTPase-activating protein 14WAVE-associated Rac GTPase-activating proteinSLIT-ROBO Rho GTPase activating protein 3
02

Biological functions

Negative regulation of cell migrationRegulation of postsynapse assemblySignal transductionRegulation of small GTPase-mediated signal transductionCytoskeletal remodeling, especially in neuronsRegulation of neuronal migration and axonal branching
03

Disease associations

Neurodevelopmental disorders (e.g., mental retardation/intellectual disability)Chromosome 3p deletion syndromePilomyxoid astrocytoma
04

Safety considerations

Potential involvement in cognitive impairment and neurodevelopmental disorders if dysregulated or mutated

Beyond the preview

Go deeper on SLIT-ROBO Rho GTPase-activating protein 3 (SRGAP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLIT-ROBO Rho GTPase-activating protein 3 (SRGAP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call